Tissue plasminogen activator: hospital experience.
Tissue plasminogen activator (t-PA) is administered safely and efficiently in the treatment of acute myocardial infarction (MI). A study of 74 patients administered t-PA for acute MI associated with a low complication rate showed an acceptable patency rate, and a good outcome.
LiMandri
G
G
Cardiopulmonary Department, Overlook Hospital, Summit, NJ 07901.
Dunn
D
D
Burd
C
C
Gregory
J
J
D000328:Adult; D000368:Aged; D017023:Coronary Angiography; D004562:Electrocardiography; D005260:Female; D006764:Hospitals, Community; D006801:Humans; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000175:diagnosis / Q000000981:diagnostic imaging / Q000188:drug therapy*; D009515:New Jersey; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000627:therapeutic use*
D010959:Tissue Plasminogen Activator